Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
01st week of 2017 patent applcation highlights part 9
Patent application number
Title
Published
20170000803
PROGESTERONE FORMULATIONS HAVING A DESIRABLE PK PROFILE
2017-01-05
20170000804
Methods and Compositions for Inhibiting Mitochondrial Trafficking
2017-01-05
20170000805
FOOD SUPPLEMENTATION COMPOSITION CONTAINING ONE OR MORE VITAMIN D3 COMPOUNDS AND ONE OR MORE MAGNESIUM SALTS
2017-01-05
20170000806
CO-CRYSTALS OF TRAMADOL AND COXIBS
2017-01-05
20170000807
PHARMACEUTICAL FORMULATIONS
2017-01-05
20170000808
ARGINASE INHIBITORS AS THERAPEUTICS
2017-01-05
20170000809
ARGININE SILICATE INOSITOL FOR IMPROVING COGNITIVE FUNCTION
2017-01-05
20170000810
NUTRITIONAL COMPOSITION TO REDUCE METABOLIC STRESS IN INFANTS
2017-01-05
20170000811
PREBIOTIC OLIGOSACCHARIDES
2017-01-05
20170000812
COMPOUND OF THE AVERMECTIN FAMILY OR OF THE MILBEMYCIN FAMILY FOR THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS
2017-01-05
20170000813
THERAPEUTIC COMPOSITION
2017-01-05
20170000814
THERAPEUTIC COMPOSITION
2017-01-05
20170000815
LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE
2017-01-05
20170000816
HYALURONIC ACID GEL COMPOSITION HAVING DURABILITY
2017-01-05
20170000817
IONIC AQUEOUS COMPOSITIONS
2017-01-05
20170000818
NYLON-3 POLYMERS ACTIVE AGAINST CLOSTRIDIUM DIFFICILE
2017-01-05
20170000819
NOVEL OPHTHALMIC COMPOSITION AND METHODS OF USE
2017-01-05
20170000820
ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN AND NAILS
2017-01-05
20170000821
HAND DISINFECTANT
2017-01-05
20170000822
METHOD BASED ON BISMUTH ION FOR THE TREATMENT AND PREVENTION OF A DISEASE CAUSED BY A SHIGA TOXIN
2017-01-05
20170000823
METHODS OF TREATMENT USING TOPICAL COPPER ION FORMULATIONS
2017-01-05
20170000824
DRUG DELIVERY COMPOSITIONS AND METHODS
2017-01-05
20170000825
HUMAN FACILITATING CELLS
2017-01-05
20170000826
Methods and Devices for Preparation of Enriched Biological Fluids
2017-01-05
20170000827
BROWN ADIPOCYTE MODIFICATION
2017-01-05
20170000828
ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES
2017-01-05
20170000829
PERIPLANETA AMERICANA EXTRACT OR PERIPLANETA AMERICANA MEDICINAL POWDER AS WELL AS PREPARATION METHOD THEREOF AND APPLICATION IN PREPARATION FOR MEDICINE USED FOR PREVENTING AND TREATING RADIATION-INDUCED DAMAGES
2017-01-05
20170000830
Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof
2017-01-05
20170000831
PHAGE THERAPY OF E COLI INFECTIONS
2017-01-05
20170000832
COMBINATION METHOD FOR TREATMENT OF CANCER
2017-01-05
20170000833
POLYSACCHARIDES FROM PRASINOCOCCALES
2017-01-05
20170000834
NUTRITIONAL COMPOSITIONS FOR REDUCING INTESTINAL PATHOGENS
2017-01-05
20170000835
METHOD FOR TREATING SPINOCEREBELLAR ATAXIAS
2017-01-05
20170000836
Prognostic and Diagnostic Methods and Herbal Therapies for Treating Skin Conditions, Autoimmune Diseases, Inflammatory Ailments and Cancer
2017-01-05
20170000837
Prognostic and Diagnostic Kits and Herbal Therapies for Treating Skin Conditions, Autoimmune Diseases, Inflammatory Ailments and Cancer
2017-01-05
20170000838
DAPHNE LAUREOLA EXTRACTS IN THE TREATMENT OF DERMOPATHIES
2017-01-05
20170000839
METHOD FOR PRODUCING DRY EXTRACTS
2017-01-05
20170000840
METHODS FOR PREVENTING AND TREATING ORAL CANCERS
2017-01-05
20170000841
TREATMENT OF KLEBSIELLA PNEUMONIAE WITH LIPOSOMALLY FORMULATED GLUTATHIONE
2017-01-05
20170000842
SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF
2017-01-05
20170000843
COMPOSITIONS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
2017-01-05
20170000844
Treatment of Ascites
2017-01-05
20170000845
ROMIDEPSIN FORMULATIONS AND USES THEREOF
2017-01-05
20170000846
USE OF A NEUROFILAMENT PEPTIDE FOR THE TREATMENT OF GLIOMA
2017-01-05
20170000847
HUMAN FERTILITY ENHANCEMENT WITH CORTISOL REDUCTION FOOD
2017-01-05
20170000848
Short Bio-Active Peptides for Promoting Wound Healing
2017-01-05
20170000849
CD300A RECEPTORS AS VIRUS ENTRY COFACTORS
2017-01-05
20170000850
DIFFERENTIATION THERAPY WITH CD137 LIGAND AGONISTS
2017-01-05
20170000851
PTD-SMAD7 THERAPEUTICS
2017-01-05
20170000852
GOBLET CELL REPLACEMENT THERAPY
2017-01-05
20170000853
WOUND HEALING COMPOSITION
2017-01-05
20170000854
NOVEL ALBUMIN-FREE FACTOR VIII FORMULATIONS
2017-01-05
20170000855
METHOD FOR THE PREPARATION OF HUMAN ALBUMIN WITH REDUCED LEVEL OF DISSOLVED OXYGEN
2017-01-05
20170000856
DIETARY SUPPLEMENTS AND FORMULATIONS
2017-01-05
20170000857
NEW TARGET FOR DIABETES TREATMENT AND PREVENTION
2017-01-05
20170000858
COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
2017-01-05
20170000859
NON-NATURAL RIBONUCLEASE CONJUGATES AS CYTOTOXIC AGENTS
2017-01-05
20170000860
ULTRAPURE HYPOALLERGENIC SOLUTIONS OF SACROSIDASE
2017-01-05
20170000861
PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY CONTAINING FACTOR VII FUSION PROTEIN
2017-01-05
20170000862
ENGINEERED CHIMERIC PEGYLATED ADI AND METHODS OF USE
2017-01-05
20170000863
THERAPEUTIC AGENT FOR DISC HERNIATION
2017-01-05
20170000864
COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN BONE MARROW TRANSPLANTATION AND TREATMENT OF GRAFT VERSUS HOST DISEASE
2017-01-05
20170000865
DNA Vaccines Encoding Heat Shock Proteins
2017-01-05
20170000866
METHOD FOR EMULSIFYING A TRIEPITOPE PEPTIDE WITH MONTANIDE AND KITS FOR PERFORMING THE SAME
2017-01-05
20170000867
VACCINE COMPOSITIONS AND METHODS FOR RESTORING NKG2D PATHWAY FUNCTION AGAINST CANCERS
2017-01-05
20170000868
COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
2017-01-05
20170000869
Compositions and Methods for Treating Immunological Dysfunction
2017-01-05
20170000870
COMBINATION THERAPY FOR IMMUNOSTIMULATION
2017-01-05
20170000871
COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
2017-01-05
20170000872
INACTIVATED BACTERIAL CELL FORMULATION
2017-01-05
20170000873
Dimethyl Fumarate and Vaccination Regimens
2017-01-05
20170000874
NOVEL MENINGOCOCCAL CONJUGATE VACCINE FOR GROUPS A, C, Y AND W135 AND A PREPARATION METHOD THEREOF
2017-01-05
20170000875
TOXOID PREPARATION AND USES THEREOF
2017-01-05
20170000876
METHOD FOR THE VACCINATION AGAINST HIV
2017-01-05
20170000877
MONOVALENT H5 VACCINE
2017-01-05
20170000878
CONSTRAINED IMMUNOGENIC COMPOSITIONS AND USES THEREFOR
2017-01-05
20170000879
Compositions and Methods for the Treatment or Prevention of Hepatitis B Virus Infection
2017-01-05
20170000880
MILK-BASED PROTEIN HYDROLYSATES AND INFANT FORMULAE AND NUTRITIONAL COMPOSITIONS MADE THEREOF
2017-01-05
20170000881
ENHANCING THE T-CELL STIMULATORY CAPACITY OF HUMAN ANTIGEN PRESENTING CELLS IN VITRO AND IN VIVO AND ITS USE IN VACCINATION
2017-01-05
20170000882
Genetically Detoxified Pertussis Vaccine that Maintains Intrinsic Adjuvant Activity
2017-01-05
20170000883
SUPERANTIGEN POST-EXPOSURE THERAPY
2017-01-05
20170000884
STAT3 PHOSPHORYLATION DURING GRAFT-VERSUS-HOST DISEASE
2017-01-05
20170000885
METHODS OF TREATING CANCER USING ANTI-OX40 ANTIBODIES AND PD-1 AXIS BINDING ANTAGONISTS
2017-01-05
20170000886
MESENCHYMAL STEM CELLS FOR TARGETED CANCER THERAPY
2017-01-05
20170000887
UNIFORM CORE-SHELL TIO2 COATED UPCONVERSION NANOPARTICLES AND USE THEREOF
2017-01-05
20170000888
NANOSTRUCTURED GELS CAPABLE OF CONTROLLED RELEASE OF ENTRAPPED AGENTS
2017-01-05
20170000889
STABLE BROMFENAC OPHTHALMIC SOLUTION
2017-01-05
20170000890
PHARMACEUTICAL FORMULATION FOR ADMINISTRATION OF MEDICINES
2017-01-05
20170000891
FOOD COMPOSITION
2017-01-05
20170000892
STABILIZING COMPOSITION FOR BIOLOGICAL MATERIALS
2017-01-05
20170000893
COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY
2017-01-05
20170000894
COMPOSITIONS AND METHODS FOR MODIFYING THE SURFACE OF CELLS AND METHODS OF USE
2017-01-05
20170000895
LONG ACTING LUTEINIZING HORMONE (LH) COMPOUND
2017-01-05
20170000896
PRO-DRUG FORM (P2PDOX) OF THE HIGHLY POTENT 2-PYRROLINODOXORUBICIN CONJUGATED TO ANTIBODIES FOR TARGETED THERAPY OF CANCER
2017-01-05
20170000897
MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
2017-01-05
20170000898
Therapeutic Biologic for Treatment of Hepatocellular Carcinoma
2017-01-05
20170000899
RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERY
2017-01-05
20170000900
ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODY COMBINATIONS
2017-01-05
20170000901
DLL3 MODULATORS AND METHODS OF USE
2017-01-05
20170000902
EGFR-TARGETED NANOPARTICLES
2017-01-05